Depletion of YTHDF1 in DCs in mouse models enhances cross-presentation of tumor antigens, promotes their cross-priming with CD8+ T and increases the infiltration of neoantigen-specific CD8+ T cells in the tumor microenvironment, thus enhancing antitumor immunity. This evidence concerns the gene CD8A and neoplasm.